Results 121 to 130 of about 768 (137)
Design Considerations, Formulation Approaches, and Strategic Advances of Hydrogel Platforms for Tendinopathy Management. [PDF]
Lin J +6 more
europepmc +1 more source
Research Progress on Strategies for Improving the Enzyme Properties of Bacteriophage Endolysins. [PDF]
Wang Y, Wang X, Liu X, Lin B.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
PCNP: A RoCEv2 congestion control using precise CNP
Computer NetworksFang Binxing, Yan DingYu, Yaping Liu
exaly +2 more sources
PCNP: A new era in shaping health policy
Journal of the American Association of Nurse Practitioners, 2020ABSTRACT The Pennsylvania Coalition of Nurse Practitioners (PCNP) is the state organization that promotes and protects the practice of more than 15,000 certified registered nurse practitioners in Pennsylvania. PCNP, credited for many legislative successes related to nurse practitioner (NP) practice since the 1980s, continues to expand its ...
Adele Marie, Caruso, Cheryl, Schlamb
openaire +2 more sources
The PCNP/β-Catenin Axis Promotes Ovarian Cancer Progression
SSRN Electronic Journal, 2019PCNP is associated with human cancers including neuroblastoma and lung cancer. However, the role and underlying molecular mechanism of PCNP have not been plenty elucidated. Herein, we first investigated the effects of PCNP in ovarian cancer proliferation, apoptosis, migration and invasion and determined the molecular mechanism of PCNP in ovarian cancer
Pengzhen Dong +8 more
openaire +1 more source
Advanced Healthcare Materials, 2018
AbstractSmall‐sized cationic miRi (microRNA‐21 inhibitor)‐PCNPs (low molecular weight chitosan (LMWC)‐modified polylactide‐co‐glycoside (PLGA) nanoparticles (PLNPs)) with special kidney‐targeting and high‐efficiency antifibrosis treatment are fabricated through coupling miRi, PLGA, and LMWC.
Xinran Geng +8 more
openaire +2 more sources
AbstractSmall‐sized cationic miRi (microRNA‐21 inhibitor)‐PCNPs (low molecular weight chitosan (LMWC)‐modified polylactide‐co‐glycoside (PLGA) nanoparticles (PLNPs)) with special kidney‐targeting and high‐efficiency antifibrosis treatment are fabricated through coupling miRi, PLGA, and LMWC.
Xinran Geng +8 more
openaire +2 more sources
Depression Screening in Adolescents: Implications for PCNPs
The Journal for Nurse Practitioners, 2022openaire +1 more source

